About admin

This author has not yet filled in any details.
So far admin has created 40 entries.
  • Permalink Gallery

    INFARMA Announces Joint Statement with Regional Chamber of Physicians in Warsaw

INFARMA Announces Joint Statement with Regional Chamber of Physicians in Warsaw

INFARMA, the Polish association for the innovative pharmaceutical industry, is pleased to announce that a joint position regarding conflict of interest has been adopted by the Regional Chamber of Physicians in Warsaw and INFARMA . The document states that cooperation between innovative pharmaceutical companies and the medical environment is a natural element of the healthcare […]

  • Permalink Gallery

    Report – Going Live: Implementation of the Disclosure Code

Report – Going Live: Implementation of the Disclosure Code

EFPIA’s ‘Code on Disclosure of Transfers of Value from Pharmaceutical Companies to Healthcare Professionals and Healthcare Organisations’ has now gone live, with member companies in 33 countries starting to collect data. Representatives of practitioners, patients and the industry met at the end of January to discuss the next steps in implementation.

EVENT – Going Live: Implementation of the Disclosure Code – Agenda

How does the pharmaceutical disclosure code affect health care providers?

 

ABOUT THE EVENT – AGENDA – REPORT – DOWNLOADS & VIDEO 

 9.30

 Registration and welcome coffee

 10.00

 A view from Brussels – Financial Disclosure and Public Policy

Lode Wigersma, Former Director, Royal Dutch Medical Association
Carin Smand, Managing Director, European Hematology Association
Anne Britta Haas, Counsel, Clifford Chance
Bernard Maillet, VP eHealth, CPME
Cees Smit, Patient advocate and policy advisor, EGAN

moderator: […]

  • Permalink Gallery

    Leading Polish Physician Expresses Doubts About Financial Transparency

Leading Polish Physician Expresses Doubts About Financial Transparency

By Zbigniew Gaciong


Implementing EFPIA’s code on transfers of value involves an inequitable level of disclosure by individual doctors and will leave members of the medical profession in Poland open to media sensation, says Zbigniew Gaciong, Chairman of the Department of Internal Medicine, Hypertension and Vascular Diseases at the Medical University of Warsaw
  • Permalink Gallery

    Ensure the Benefits of Financial Transparency are Properly Understood

Ensure the Benefits of Financial Transparency are Properly Understood

By Athanasios Exadaktylos


While financial transparency will have an important long term impact, there is potential for misunderstanding of the initiative in the short term, believes Athanasios Exadaktylos, Chairman of Thessaloniki Medical Chamber. It is essential to explain the benefits, Dr Exadaktylos says in this Q&A with pharmadisclosure.eu
  • Permalink Gallery

    Moving to Implementation: Accurate and Complete Data Helps Patients and Defuses Hype

Moving to Implementation: Accurate and Complete Data Helps Patients and Defuses Hype

by Lode Wigersma


While there is understandable concern in the medical profession that financial disclosure will fuel media sensation, the Dutch experience indicates that showing exactly how much was paid to who, for what, neutralises speculation, says Lode Wigersma, former director of the Royal Dutch Medical Association

Disclosure update from Ireland

By Gary Finnegan

Pharmaceutical firms will publish details of "transfers of value" to health professionals as part of a new industry-wide transparency drive for the first time in 2016.
  • Permalink Gallery

    Transparency Code is a “Great Opportunity” to Put Things in a Different Context

Transparency Code is a “Great Opportunity” to Put Things in a Different Context

By Konstantinos Frouzis


As Greece rebuilds after the financial crisis, adopting the EFPIA code on financial disclosure will be a source of greater confidence, improving the environment for investment and growth, says SFEE President Konstantinos Frouzis

Making Moves to Avoid Unintended Consequences of Disclosure

By Richard Bergström


Member companies and organisations report good headway on the technical aspects of disclosure. Now it is critical to ensure that publishing transfers of value does not deter healthcare professionals from engaging with the industry, says Richard Bergström, Director General of EFPIA
  • Permalink Gallery

    INFARMA Reports its Members are Poised to Begin Implementation

INFARMA Reports its Members are Poised to Begin Implementation

by Pawel Sztwiertnia


With only a few weeks to go, companies are ready to start collecting data and a wide-reaching communications campaign means physicians are now taking a pragmatic approach to disclosure of transfers of value, says Paweł Sztwiertnia, General Director of INFARMA, the Polish industry association